Bernstein analyst Lance Wilkes raised the firm’s price target on Centene (CNC) to $45 from $36 and keeps an Outperform rating on the shares after the company reported Q3 results. The firm sees margin recovery in Marketplace and Medicaid as driving outsized EPS growth with pricing largely addressing risk adjustment in Marketplace and risk pool shifts over the 2026/2027 time period. The firm added that it expects Medicaid margins remaining under pressure in 2026 and then normalizing over 2027-2029.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Midday Fly By: Microsoft, Nvidia invest in Anthropic
- Trump Trade: President says U.S. planning to sell F-35 jets to Saudi Arabia
- Trump says health insurance companies have ‘ripped off America long enough’
- Einhorn’s DME Capital bought PG&E and United Parks in Q3
- Trump Weekly: President set to cut tariffs on beef, coffee